FEATURED MEDICAL EDUCATION TOPIC: Allergy and Asthma Update

What is the problem?

Over 28 million people in the United States have asthma, and approximately 31% of adults have a diagnosed seasonal allergy, food allergy, or eczema. Asthma, allergy, and anaphylaxis are commonly managed in primary care, yet evolving guidelines have created gaps between evidence and practice. This activity provides practical updates on anaphylaxis management, GINA asthma recommendations (including MART therapy), atopic march progression, and early food allergen introduction. Emphasis is placed on applying guideline-based care across outpatient, ED, and inpatient settings while addressing real-world factors such as food insecurity that impact patient adherence and outcomes.

Learning Objectives

At the conclusion of this activity, the learners will be able to:

• Explain why anti-inflammatory reliever (AIR) therapy is preferred over short-acting beta2-agonists (SABA) per GINA 2025 guidelines
• Recognize and manage anaphylaxis, including appropriate use of intranasal epinephrine
• Apply clinically relevant updates from the most recent anaphylaxis practice parameters across outpatient, emergency department, and inpatient settings

If your medical staff needs a speaker on allergies and asthma, consider contacting our office to book a speaker at 714-505-4777 or info@speakersnetwork.com.

REFERENCES

https://pmc.ncbi.nlm.nih.gov/articles/PMC6776421/#:~:text=Nonpharmacologic%20Interventions,and%20smoking%20cessation%20are%20emphasized.&text=Avoidance%20of%20indoor%20allergens%2C%20targeting,remediation%20and%20cost%20of%20interventions.

https://www.nature.com/articles/s41533-024-00380-z

https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm 

https://www.cdc.gov/nchs/products/databriefs/db545.htm#:~:text=Lauren%20Bottoms%2DMcClain%2C%20M.P.H.%2C,D.%2C%20M.P.H.&text=In%202024%2C%2031.7%25%20of%20adults,%2DHispanic(6.4%25)%20adults.